These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 5813521

  • 1. Epsilon aminocaproic acid--a dangerous weapon.
    Ratnoff OD.
    N Engl J Med; 1969 May 15; 280(20):1124-5. PubMed ID: 5813521
    [No Abstract] [Full Text] [Related]

  • 2. Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy.
    Charytan C, Purtilo D.
    N Engl J Med; 1969 May 15; 280(20):1102-4. PubMed ID: 5778426
    [No Abstract] [Full Text] [Related]

  • 3. Intravascular coagulation and glycerin hemoglobinuric acute renal failure.
    Wardle EN, Wright NA.
    Arch Pathol; 1973 Apr 15; 95(4):271-5. PubMed ID: 4572188
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of hematuria in hemorrhagic diathesis by means of epsilon-aminocaproic acid with concomitant determination of urokinase].
    Cohen I, Djaldetti M, Gorshein D, de Vries A.
    Folia Clin Int (Barc); 1965 Nov 15; 15(11):537-8. PubMed ID: 5867570
    [No Abstract] [Full Text] [Related]

  • 5. Amicar and hyperfibrinolysis.
    Med Lett Drugs Ther; 1967 Jan 10; 9(3):10-1. PubMed ID: 6067964
    [No Abstract] [Full Text] [Related]

  • 6. [Feeding trials with epsilon-aminocaproic acid in animal experiments and its effect on the vascular system].
    Kommerell B, Fritsch H, Gilsdorf U.
    Z Gesamte Exp Med Einschl Exp Chir; 1966 Jan 10; 140(3):191-201. PubMed ID: 5992167
    [No Abstract] [Full Text] [Related]

  • 7. Aminocaproic acid in prolonged hematuria of patients with sicklemia.
    Black WD, Hatch FE, Acchiardo S.
    Arch Intern Med; 1976 Jun 10; 136(6):678-81. PubMed ID: 1275623
    [Abstract] [Full Text] [Related]

  • 8. [Triggering of massive thrombus formation with epsilon-aminocaproic acid after previous activation of the coagulation system].
    Herschlein HJ, Steichele DF.
    Thromb Diath Haemorrh; 1967 May 31; 17(3-4):568-77. PubMed ID: 5589304
    [No Abstract] [Full Text] [Related]

  • 9. Incidence of thrombosis associated with epsilon-aminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. A study in experimental animals and in clinical material.
    Becker J, Borgström S.
    Acta Chir Scand; 1968 May 31; 134(5):343-9. PubMed ID: 5731268
    [No Abstract] [Full Text] [Related]

  • 10. Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience.
    Nilsson IM, Andersson L, Björkman SE.
    Acta Med Scand Suppl; 1966 May 31; 448():1-46. PubMed ID: 5221699
    [No Abstract] [Full Text] [Related]

  • 11. [Urinary incidents in the treatment of hematuria in hemophiliacs with epsilon-aminocaproic acid].
    Goudemand M, Parquet-Gernez A, Deconninck B.
    Lille Med; 1968 Apr 31; 13(4):408-12. PubMed ID: 5684775
    [No Abstract] [Full Text] [Related]

  • 12. [Therapy with epsilon-aminocaproic acid].
    Böhnel J, Stacher A.
    Wien Med Wochenschr; 1966 Feb 19; 116(8):157-61. PubMed ID: 5983046
    [No Abstract] [Full Text] [Related]

  • 13. [Epsilon aminocaproic acid and hematurias in hemophiliacs. 3 cases of transient unilateral renal obstruction].
    Sultan Y, Larrieu MJ, Meyer D, Caen J, Bernard J.
    Bibl Haematol; 1966 Feb 19; 26():100-6. PubMed ID: 5955955
    [No Abstract] [Full Text] [Related]

  • 14. Aminocaproic acid (EACA) therapy for neonatal post-renal biopsy bleeding with renal failure.
    Heldrich FJ, Salcedo UT, Salcedo JR, Herrera AJ.
    Md State Med J; 1982 Jul 19; 31(7):32-3. PubMed ID: 7109696
    [No Abstract] [Full Text] [Related]

  • 15. [Peculiarities of the clinical picture and treatment of hematuria in patients with hemophilia].
    Papain LP, Aksenov NA, Fedorova ZD, Alekseev RA, Volkova SD.
    Probl Gematol Pereliv Krovi; 1976 Jan 19; 21(1):27-30. PubMed ID: 1273060
    [No Abstract] [Full Text] [Related]

  • 16. [The influence of fibrinolysis inhibitors on the effect of bioactive substances on the guinea pig ileum. Studies on the problem of the effect of epsilon-aminocaproic acid, acetyl-epsilon-aminocaproic acid and p-aminomethylbenzoic acid].
    Doleschel W, Auerswald W.
    Wien Med Wochenschr; 1966 Feb 12; 116(7):130-4. PubMed ID: 4293171
    [No Abstract] [Full Text] [Related]

  • 17. Measurement of fibrinolytic activity after epsilon-aminocaproic acid administration in rats (Rattus norvegicus).
    Gogjian MA, Barry KJ, Stein BM.
    Lab Anim Sci; 1981 Dec 12; 31(6):710-1. PubMed ID: 7343767
    [Abstract] [Full Text] [Related]

  • 18. [Surgical complications caused by fibrinolysis and their treatment following prostate surgery].
    Wölfer E, Mihalecz K, Karátson A, Nagy I.
    Z Urol Nephrol; 1967 Dec 12; 60(12):853-7. PubMed ID: 4174722
    [No Abstract] [Full Text] [Related]

  • 19. [Effects of epsilon-aminocaproic acid, amben and kontrikal on fibrinolysis due to tissue-type plasminogen activator from the pig heart].
    Shimonaeva EE, Andreenko GV, Alieva NI.
    Farmakol Toksikol; 1986 Dec 12; 49(4):35-8. PubMed ID: 2428660
    [Abstract] [Full Text] [Related]

  • 20. Epsilon-aminocaproic acid in traumatic renal hematuria in the rabbit.
    Laungani GB, Beyer MM, Friedman EA.
    Invest Urol; 1975 May 12; 12(6):458-60. PubMed ID: 1120637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.